Clinical Trials Browser

Phase 1/2 × Cholangiocarcinoma × Drug Therapy × Clear all

Cholangiocarcinoma

NCT00041808 2005-06-24

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

BreastDermatologicGastrointestinalSarcomaThoracic

Breast Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

Clinical Trials

PULSAR Combined With Immunotherapy and Chemotherapy

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver